DRKS00021473招募中4 期
aser therapy for OAB and vaginal atrophy - a randomised intervention study
St. Josefs Hospital Wiesbaden0 个研究点目标入组 100 人开始时间: 2020年7月30日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- Female
入选标准
- •Informed consent
- •- legal age
- •- normal Pap smear
- •- symptoms consistent with vaginal atrophy and OAB requiring treatment
排除标准
- •known neurological cause of OAB
- •- residual urine ( > 150ml)
- •- urinary tract infection, pregnancy, vaginal infection/wound, menstruation, light-allergy
- •- current use of vaginal estrogens
- •- current use of anticholinergic medications or mirabegron
- •- current use of anticoagulants (except ASS)
研究者
相似试验
尚未招募
不适用
Treatment of vaginal atrophy using fractional micro ablative carbon dioxide (CO2) laser in post-menopausal women with breast cancer on aromatase inhibitors: a pilot studyGenitourinary syndrome of MenopauseVulval-vaginal atrophyBreast cancerACTRN12617000287336Australia and New Zealand Breast Cancer Trials Group36
已完成
不适用
Elastographic Improvement of Vaginal Atrophy Treated by Erbium Yag LaserVaginal AtrophyLaserDyspareuniaGenitourinary Syndrome of Menopause (GSM)NCT06000202Istanbul University - Cerrahpasa20
终止
3 期
A Trial to Evaluate the Efficacy of Low Dose Vaginal Estrogens in the Treatment of Atrophic VaginitisAtrophic VaginitisNCT00816556Maire Mac Bride63
已完成
2 期
An Efficacy Study of Vagitocin in Postmenopausal Women With Symptoms of Vaginal AtrophyAtrophyNCT02497547PepTonic Medical AB227
终止
4 期
Ospemifene vs. Conjugated Estrogens in the Treatment of Postmenopausal Sexual DysfunctionSexual Dysfunction, PhysiologicalNCT03018106Emory University1